Navigation Links
Cambrex Reports Fourth Quarter and Full Year 2008 Results
Date:2/11/2009

igit growth again in 2009. We are also projecting strong growth in certain of our drug delivery products this year. We continue to believe that these segments of our business combined with our portfolio of late stage clinical products position us to achieve longer term growth."

Fourth Quarter 2008 Interest, Tax and Other Expenses - Continuing Operations

Net Interest Expense in the fourth quarter 2008 was $1.4 million compared to $0.9 million in the fourth quarter 2007. The Company capitalized interest of $0.2 million on long-term projects in the fourth quarter of 2008.

The Provision for Income Taxes totaled $1.1 million in the fourth quarter 2008. The Company's effective tax rates have been and are expected to remain highly sensitive to the geographic mix of income due to the Company's inability to recognize tax benefits for U.S. GAAP purposes in certain jurisdictions where there has been a recent history of losses, primarily the U.S.

Strategic Alternative and Restructuring Costs totaling $3.3 million in the fourth quarter 2008 include $2.7 million of charges related to the consolidation of operations at the New Jersey technical center into the Iowa facility. The fourth quarter charges result from a negative outlook regarding the Company's ability to sublease the facility prior to the December 2010 lease expiration. Expenses related to the sale of the Bio Businesses constitute the remainder of these fourth quarter costs.

Fourth Quarter 2008 Capital Expenditures and Depreciation

Capital expenditures and depreciation for the fourth quarter 2008 were $7.3 million and $4.9 million compared to $11.6 million and $5.3 million in the fourth quarter 2007, respectively. The decrease in capital spending is largely due to higher fourth quarter 2007 spending on two large capital projects for which the majority of spending has since been compl
'/>"/>

SOURCE Cambrex Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Cambrex To Announce Third Quarter 2007 Financial Results on November 1, 2007
2. Cambrex Signs Agreement To Acquire ProSyntest AS
3. Cambrex Reports Fourth Quarter and Full-Year 2007 Results
4. Cambrex Customer Announced Recall
5. Cambrex to Announce First Quarter 2008 Financial Results on May 1, 2008
6. Cambrex Presentation at The JPMorgan Healthcare Conference to be Webcast
7. Skinvisible and Cambrex Enter Into Agreement to Develop Acne Products
8. Cambrex to Announce Fourth Quarter 2008 Financial Results on February 11, 2009
9. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
10. Haemacure Reports Third Quarter 2007 Results
11. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... military personnel who served in Iraq and Afghanistan ... injury (TBI) were compared to military personnel without ... Differences in measures of overall disability, cognitive function, ... are reported in an article in Journal ... Ann Liebert, Inc., publishers. The article is available ...
(Date:4/17/2014)... cause of neuronal death in Parkinson,s disease is still ... be mistaken for foreign invaders and killed by the ... diseases like type I diabetes, celiac disease, and multiple ... April 16, 2014, in Nature Communications . , ... Parkinson,s disease; but if true, it could lead to ...
(Date:4/17/2014)... of Medicine (BUSM) have discovered that the anti-seizure ... model. The findings, reported in the American ... lead to more effective treatments for alcoholism. , ... leading causes of illness and death in the ... limiting the productivity of workers and necessitating huge ...
(Date:4/17/2014)... has the potential to ward off depression among retirees, ... published online in The Journals of Gerontology, ... In the article " Internet Use and Depression Among ... Analysis ," the authors report that Internet use reduced ... among their study sample. , Late-life depression affects ...
(Date:4/17/2014)... ribbon representing a disease. A pink ribbon is well known ... think of with lung cancer?, Although white has been identified ... black may be the only one they think fits., A ... smokers between the ages of 51 to 79 years old, ... these patients, the emotional toll it can have and how ...
Breaking Medicine News(10 mins):Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Is Parkinson's an autoimmune disease? 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Internet use may cut retirees' depression 2Health News:Unraveling the 'black ribbon' around lung cancer 2
... of intestinal stem cells that may hold clues to the ... reported March 30 in the journal Cell , appears ... recent discovery of intestinal stem cells that multiply rapidly ... as a "brake" on cell growth and proliferation. , The ...
... renal cell carcinoma, the second most common kidney cancer subtype, ... after surgery. Those are the key findings of a multi-centre ... of the urology journal BJUI . ... to 15% of kidney cancer patients, the small number of ...
... R.I. Rhode Island Hospital physicians identified ... that required endoscopic or surgical removal. The paper calls attention ... aware of this potential danger. It is published in the ... online in advance of print. David Grand, M.D., a ...
... , WEDNESDAY, March 28 (HealthDay News) -- In ... the popular antidepressant Celexa can cause potentially fatal abnormal ... issued new dosing and use recommendations. Last August, ... than 40 milligrams a day can cause changes in ...
... radiation therapy (IMRT) instead of standard whole breast irradiation ... toxicities, according to a study in Practical Radiation ... journal of the American Society for Radiation Oncology (ASTRO)., ... effective breast cancer treatment that also reduces the incidence ...
... (HealthDay News) -- The common cold appears to increase ... makes them more sensitive, which triggers coughing, wheezing and ... are especially vulnerable to this virus-induced coughing, said the ... are known as transient receptor potential (TRP) receptors. ...
Cached Medicine News:Health News:Newly identified stem cells may hold clues to colon cancer 2Health News:Kidney cancer subtype study finds low recurrence and cancer death rates 2Health News:Rhode Island Hospital study identifies the danger of grill brushes 2Health News:FDA Adds More Warnings to Antidepressant's Label 2Health News:IMRT reduces risk of side effects in breast cancer patients 2Health News:Research Shows How Colds Lead to Coughing, Wheezing 2
(Date:1/15/2014)... , Jan. 15, 2014 As health officials across ... virus, select Meijer pharmacies in Michigan ... to eligible patients, enabling Meijer pharmacists to administer tests and, ... set by a physician participating in the study. ...
(Date:1/15/2014)... OAKS, Calif. , Jan. 15, 2014 ... Amgen (NASDAQ: AMGN ) announced today ... jointly discover and validate new therapeutic targets and ... a chronic disorder that affects millions worldwide. The ...
(Date:1/15/2014)...  Manufacturers, suppliers and distributors of innovative medical-related products ... most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the Medical ... most litigious industry sectors of cases involving IP ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Intellectual Property Insurance for Medical-related Products and Services 2
... Calif., Jan. 6, 2011 Genesis ... ), a biotechnology company developing targeted cancer therapies, announces that ... Biotech Showcase™ 2011 conference on Wednesday, January 12, 2011, at ... the Parc 55 Wyndham San Francisco – Union Square. ...
... Jan. 5, 2011 WebMD Health Corp. (Nasdaq: ... million of Convertible Notes due 2018 in a private placement. ... proposed offering an option to purchase up to an additional ... being offered only to qualified institutional buyers pursuant to Rule ...
Cached Medicine Technology:Genesis Biopharma to Present at 2011 Biotech Showcase Conference 2WebMD Announces Proposed Offering of Convertible Notes 2
Boston Multivision design is manufactured in Boston ES material for early presbyope patients. Boston Multivision lens provides crisp, clear vision at near, intermediate, and far distances and excelle...
Ophthalmic surgery stretcher. Designed for exceptional surgeon access, ideal for either superior or temporal approach....
... Reliance mobile surgical stretcher. M-701 ... of 24 in. to 32 in., ... You may specify a high range, ... A 4 in. pad can be ...
... Visionblue is a staining solution for ... required for performing a safe phaco-emulsification ... lens capsule may result in an ... risk of radial capsule tears and ...
Medicine Products: